好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2023 Fall Conference | C26 - Neurology Update 8: Neuromuscular Disease and Autonomic Disorders

Sunday 10/29/23
09:30 AM - 11:00 AM PDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Robert M. Pascuzzi, MD, FAAN
Neuromuscular and Clinical Neurophysiology (EMG)
Attendees should become familiar with expanding options in the treatment of myasthenia gravis; enhance their understanding of management considerations for patients with motor neuron disease; and acquire clinical pearls in the diagnosis and treatment of myopathies, neuropathies, and disorders of the neuromuscular junction. Attendees should also learn how to develop a diagnostic approach to the patient with autonomic failure; understand the natural history and disease trajectory of patients with autonomic failure; and be able to develop a differential diagnosis of patients presenting with autonomic features.
1.50 CME credits
Event Timeline
09:30 AM - 10:15 AM PDT Speaker Neuromuscular
Robert M. Pascuzzi, MD, FAAN
10:15 AM - 11:00 AM PDT Speaker Autonomic Disorders
Roy L. Freeman, MD
Faculty Disclosures
Robert M. Pascuzzi, MD, FAAN Dr. Pascuzzi has nothing to disclose.
Roy L. Freeman, MD Dr. Freeman has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cutaneous Diagnostic Life Sciences. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theravance. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Inhibikase. Dr. Freeman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Freeman has received research support from NIH. The institution of Dr. Freeman has received research support from Theravance. The institution of Dr. Freeman has received research support from Biohaven. The institution of Dr. Freeman has received research support from Lundbeck. Dr. Freeman has received research support from Regeneron.